Daniel Schneeberger
Daniel Schneeberger has made 8 open-market purchases worth $1.7M since Sep 16, 2026, in 3 companies. The latest: $54k of NXTC, filed Oct 27, 2026, scored 12 out of 100.
10% owner, NextCure, Inc. 10% owner, InMed Pharmaceuticals Inc. 10% owner, TENAX THERAPEUTICS, INC.
Follow Daniel Schneeberger, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 27 Form 4 (opens sec.gov) |
NXTCNextCure, Inc. · 10% owner10% owner | +2% stake | 12 | $54k 10,851 at $4.95 |
waiting | waiting |
| Oct 27 Form 4 (opens sec.gov) |
INMInMed Pharmaceuticals Inc. · 10% owner10% owner · Penny stock: hard to trade | +0% stake | 10 | $5 4 at $1.32 |
— | — |
| Oct 21 Form 4 (opens sec.gov) |
TENXTENAX THERAPEUTICS, INC. · 10% owner10% owner · Near 52-week low · Penny stock: hard to trade | +14% stake | 25 | $1.5M 922,849 at $1.59 |
+5.7% | waiting |
| Oct 20 Form 4 (opens sec.gov) |
INMInMed Pharmaceuticals Inc. · 10% owner10% owner · Penny stock: hard to trade | +0% stake | 10 | $1k 1,087 at $1.32 |
— | — |
| Oct 15 Form 4 (opens sec.gov) |
INMInMed Pharmaceuticals Inc. · 10% owner10% owner · Penny stock: hard to trade | +1% stake | 10 | $13k 9,569 at $1.33 |
— | — |
| Oct 8 Form 4 (opens sec.gov) |
INMInMed Pharmaceuticals Inc. · 10% owner10% owner · Near 52-week low · Penny stock: hard to trade | +1% stake | 6 | $14k 10,903 at $1.33 |
— | — |
| Oct 5 Form 4 (opens sec.gov) |
INMInMed Pharmaceuticals Inc. · 10% owner10% owner · Near 52-week low · Penny stock: hard to trade | +5% stake | 10 | $57k 42,920 at $1.33 |
+0.0% | waiting |
| Sep 16 Form 4 (opens sec.gov) |
INMInMed Pharmaceuticals Inc. · 10% owner10% owner · Near 52-week low · Penny stock: hard to trade | +11% stake | 19 | $118k 91,101 at $1.30 |
+0.7% | −1.8% |
Track record (hypothetical): a week after the filing, these buys averaged +2.1% (67% up, 3 measured); a month after, −1.8% (0% up, 1 measured).
Questions
What stock has Daniel Schneeberger bought?
NXTC (NextCure, Inc.), INM (InMed Pharmaceuticals Inc.), TENX (TENAX THERAPEUTICS, INC.), all on the open market and reported on SEC Form 4.
When did Daniel Schneeberger last buy?
Oct 27, 2026: 10,851 shares of NXTC at $4.95, $54k in all (Form 4 (opens sec.gov)).
Has Daniel Schneeberger filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Daniel Schneeberger a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 27, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer